“…Recent conflicting reports have retrospectively queried databases (using a directly supplied, manufacturer database (26), or the FDA's Manufacturer and User Facility Device Experience (25)) to evaluate the safety of DRG stimulation. Their estimates of adverse event are discrepant, particularly on lead migration and lead fracture (31,32), which were major contributors to complications in our cohort. The prospectively collected complications‐data in our cohort contribute to this debate of long‐term safety of DRG stimulation (in addition to its long‐term efficacy).…”